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Summary 
We previously reported that one of the main components of the sclerotic material in human 
glomerular diseases  was type IV collagen. In this study we examined the contribution of increased 
synthesis to this process at the gene expression level. Sufficient material has not been available 
to study type IV collagen synthesis by normal or sclerotic glomeruli in humans. We took advantage 
of the availability of nephrectomy specimens from patients  with renal carcinoma,  and of the 
observation that approximately 50% of these patients develop  varying degrees of  glomertflosderosis. 
We microdissected glomeruli from 10 patients and analyzed them using in situ reverse  transcription 
coupled with polymerase chain reaction (PCR) analyses  (in situ RT-PCR). ce2W collagen mRNA, 
after reverse transcription  into cDNA, was detected in all patients and appeared to be increased 
in those with glomerulosclerosis (n =  5). A competitive PCR assay was developed to quantitate 
this change. There was an average 3.7-fold increase in glomerular type IV coUagen cDNA in 
patients with significant sclerosis. This change was not due to an increased number of glomerular 
cells. Thus, glomerulosclerosis in humans is associated with an devation of glomerular type IV 
collagen gene expression, suggesting that increased synthesis of type IV collagen may represent 
one component of this process. 
T 
he rates of synthesis and degradation of glomerular base- 
ment membrane components in normal glomeruli and 
the role of aberrations in these processes in the development 
of glomerulosderosis have been difficult to study in humans. 
We previously found, by immunofluorescence  microscopy, 
that  the  accumulation of extracellular  matrix in  human 
glomerulosclerosis was largely composed of type IV collagen 
(1). Studies of the mechanism of this accumulation require 
direct examination  of glomeruli, since glomerular changes 
have been shown to be regulated independently  of other cor- 
tical elements (2, 3). The techniques currently available to 
study these changes at the glomerular level are either too in- 
sensitive in the adult,  in the case of in situ hybridization in 
intact kidney (4), or require too many glomeruli in the case 
of Northern blots and ribonuclease protection assays. For these 
reasons, we developed a technique consisting of microdissec- 
tion of human glomeruli from nephrectomy specimens, fol- 
lowed by in situ reverse transcription  (RT) 1 of mRNA into 
1 Abbreviations used in this paper: PAS, periodic acid-Schiff; RT, reverse 
transcription; VRC, vanadyl  ribonucleoside  complex. 
cDNA (5, 6), and detection of o~2IV collagen cDNA by PCR. 
A competitive PCR assay was developed to quantitate glo- 
merulosclerosis-related changes in collagen type IV mRNA 
expression (7). This method of analysis allowed the repro- 
ducible measurement of the amount of c~2IV collagen cDNA 
derived from a fraction of single glomeruli. 
Materials and Methods 
Patient Population and Histology.  Kidney  tissue was obtained  after 
patient consent from 10 individuals: nine underwent unilateral 
nephrectomy  for diagnosis and/or treatment of a renal mass and 
one had an open renal biopsy for the nephrotic syndrome with 
severe  renal  insufficiency  of  unknown  duration  (see  Table 1 for demo- 
graphic and clinical data). One nephrectomy  patient (WR1), pre- 
viously diagnosed with yon Hippel Lindau syndrome,  had a be- 
nign tumor, but the rest had renal cell carcinoma. The patients 
had no history  of  diabetes mellitus, hypertension,  or other systemic 
diseases associated  with glomerular  disease. Samples  of  cortical  tissue 
distant from  obvious tumor were  placed  in Carnoy's fixative, em- 
bedded in methacrylate  or paraffin, and sections  were stained  with 
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defined as an expansion of the mesangial matrix, was independently 
evaluated by histological examination of PAS-stained  material and 
by immunofluorescence  microscopy of frozen sections after exposure 
to an antibody to type IV collagen (PHM-12, Silenus,  Westbury, 
NY). 
Glomerular Microdissection.  Several  cortical  fragments  (~10 
mm3), taken at a distance from the tumor, were placed at 4~  in 
a RNase inhibitor solution (vanadyl ribonucleoside complex [VKC]; 
Life Technologies,  Inc., Gaithersburg, MD) as previously described 
(5, 6). The fragments were transferred to a microdissecting dish 
cooled at 4~  where glomeruli were separated from tubules in the 
same RNase inhibitor  solution.  After microdissection,  isolated 
glomeruli were washed free of tissue debris and VKC in a second 
dish and transferred to a PCK tube containing a human placental 
RNase inhibitor (Boehringer Mannheim Corp., Indianapolis,  IN). 
At least 50 glomeruli were isolated from each nephrectomy, and 
20 from the one open renal biopsy. 
Pooled Glomeruli and ln Situ RT.  Glomeruli were permeabilized 
immediately before RT with a mixture containing 0.9%  Triton 
X-100,  1.2 U/#I of placental KNase inhibitor, and 5 mM dithio- 
threitol (5). Pools of five glomeruli were individually reverse tran- 
scribed with oligo dT, and 10 separate pools were combined after 
KT to lessen errors due to variations in glomerular size (8).  KT 
was performed using a cDNA synthesis kit (Boehringer Mann- 
helm Corp.) as previously described (5). Since the cDNA solution 
was found to be homogeneous in preliminary experiments, subse- 
quent manipulations were performed using fractions of the cDNA 
solution prepared from pooled glomeruli (6). 
RNA Extraction.  The yield ofcDNA from in situ KT samples 
was compared with that from KT of purified total KNA using 
25 glomeruli microdissected from each of two patients. Total RNA 
was extracted using the KNAzol method (Cinna/Biotecx, Labora- 
tories International Inc., Friendswood, TX). After KNA extrac- 
tion, an aliquot corresponding to five glomeruli (in volume) was 
reverse transcribed and the resulting cDNA compared, after PCK 
amplification, with the cDNA prepared from in  situ KT of 25 
glomernli isolated from the same patients. 
Primers.  The primers, 20-24 met, were synthesized on a PCR- 
Mate DNA synthesizer (Applied Biosystems, Inc., Foster City, CA). 
The ~2IV collagen primers were designed in the coding region 
of the NC1 domain in which unique nucleotide sequences allowed 
specific amplification of the c~2 chain, but no other type IV col- 
lagen ~  chain. The size of the amplified product was 348 bp as 
predicted from the cDNA sequence (9). Its identity was confirmed 
by restriction enzyme analysis. Controls consisted of tubes in which 
the KT enzyme had been omitted, to assure lack of amplification 
of genomic DNA encoding cx2IV collagen. These also served as 
PCK contamination controls. 
Competitive PCR Assay.  A quantitative method was established 
by developing a mutated cDNA template of a2IV collagen cDNA 
(7). A 69-bp deletion was created in the middle of the cx2IV col- 
lagen cDNA molecule, resulting in a mutant cDNA of 279 bp. 
Competitive  PCK  was  performed using  the  GeneAmp  DNA 
Amplification kit (Perkin-Elmer Cetus Corp., Norwalk, CT) as 
previously described (6). Briefly, each PCK tube contained all the 
the amplification reagents and an amount of ot2IV collagen cDNA 
template equivalent to that obtained from 1/10 of a glomerulus. 
Serial dilutions of the ~2IV collagen-mutated cDNA were added 
and the reaction mixture was amplified (see Fig. 1). Duplicate quan- 
titations of ~2IV collagen cDNA were made on pools of 50 in 
situ KT glomeruli from each of the nine nephrectomies and on 
a pool of 20 glomernli from the one renal biopsy. The range and 
relative amounts of added mutant cDNA were determined in pre- 
liminary tests (7). The thermal cycler (Perkin-Elmer Cetus Corp.) 
was programmed so that  the first incubation was performed at 
94~  x  3 min. This was followed by 34 cycles consisting of the 
following sequential steps: 94~  x  1 min, 60~  x  1 rain, and 
72~  x  3 min. The final incubation was performed at 72~  x 
7 min. 
Analysis of PCR Products.  The entire reaction mix was sepa- 
rated in a 4% Nusieve/Seakem (3:1) (FMC Bioproducts, Rockland, 
ME) agarose gel by electrophoresis. Photographs were taken with 
positive/negative  55 film (Polaroid Corp., Cambridge,/VIA) of DNA 
bands visualized with ethidium bromide staining and UV transil- 
lumination.  The gel negative was scanned by laser densitometry 
(6) (Shimadzu Scientific  Instruments Inc., Columbia, MD). The 
mutant/test cDNA ratio for each reaction tube was plotted as a 
function of the amount of mutant template and a straight line was 
drawn by linear regression analysis. The quantity ofcDNA in the 
test sample was the amount at which the mutant/test band den- 
sity ratio was equal to one (see Fig.  1) (6,  7). 
Mo~hometry.  The glomerular mean profile surface area was mea- 
sured with  a computer assisted  planimeter in 63-101  glomeruli 
(mean  =  90) using histological tissue sections (3).  The number 
of glomerular cells was counted in 10--20 consecutively encoun- 
tered glomerular profiles. The mean glomerular volume was calcu- 
lated from the harmonic mean of the glomerular equatorial area, 
using the method of De Hoff and Rhines (10) for mean size of 
Table  1.  Patient Demographic and Clinical Data 
Tumor 
Patient  Age  Sex  Scr*  Urinalysis  status 
yr  mg/dl 
WK1  35  M  1.0  Normal  Benign 
NIH4  49  M  1.2  11-20 RBC/HPF  RCCa 
1-5 WBC/HPF  Mets 
WR3  52  M  1.0  Normal  KCCa 
NIH1  50  M  1.3  11-20 RBC/HPF  RCCa 
Mets 
WK2  75  M  0.9  3-4 RBC/HPF  KCCa 
1-2 WBC/HPF 
WR6  59  F  0.8  Normal  RCCa 
NIH3  61  M  1.1  1-5 WBC/HPF  KCCa 
Mets 
KCCa 
Mets 
KCCa 
NIH2  39  F  0.8  Normal 
WK5  61  F  1.1  Normal 
WK7*  23  M  4.0  4 +  protein 
3-5  RBC/HPF 
occ gran cast 
* Abbreviations:  S~,  semm creatinine;  R.CCa, renal cell carcinoma; 
Mets, metastatic; WBC, white blood cells; HPF, high power field; occ 
gran cast, occasional granular cast. 
* WK7 was a patient undergoing  open local biopsy; all other patients 
underwent  nephrectomy for a renal mass. 
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determined for each patient using those with normal glomeruli 
as an arbitrary baseline  value. 
StatisticaIAnalysis.  The unpaired Student's t test, with the Welch 
approximation method, was used for comparisons between groups 
and a P value <0.05 was considered significant.  All data were ex- 
pressed  as mean  _+  SEM. 
Results 
Stability of ae2IV Collagen mRNA.  Preliminary experi- 
ments  revealed that  the c~2IV collagen mRNA  was  stable 
for at least 150 min in glomeruli dissected from small frag- 
ments of cortex and kept at 4~  in the presence of VRC, 
a particulate RNase inhibitor (data not shown).  Therefore, 
all subsequent RT reactions were performed within that time 
frame. The addition of a soluble, nonparticulate, RNAse in- 
hibitor  (placental)  to the tissue  transport  medium  and  the 
microdissection solution before RT did not improve the yield 
of cDNA  recovery after RT. 
In Situ RT vs Extraction of RNA.  The relative amount 
of  cDNA  obtained  from  in  situ  RT  of  microdissected 
glomeruli to that obtained after extraction and RT of RNA 
from similarly microdissected glomeruli was compared in two 
patients by standard and competitive PCR. Aliquots of cDNA 
from both preparations were amplified using o~2IV collagen 
primers.  The  density  of the  bands  obtained  after  RT  on 
glomeruli in situ was  always greater than that  after RT of 
purified  RNA  using  standard  PCR.  The differences were 
quantitated by competitive PCR. The levels of ce2IV cDNA 
obtained from extracted RNA for the two patients were 15% 
and  50%  of the values obtained with  the in  situ  RT. 
Variability of the RT Efficiency.  The efficiency of RT was 
evaluated in both in  situ  reverse-transeribed glomeruli and 
extracted total glomerular RNA. The level of oe2IV collagen 
cDNA  after in  situ  RT was  assessed by competitive PCR 
in several separate samples of 25 glomeruli from each of three 
patients, two with glomerulosderosis and one normal. The 
potential  variability in RT efl[iciency  was  also evaluated in 
separate aliquots of glomerular RNA obtained from each of 
these patients. These experiments (data not shown) revealed 
an intersample variability of  _+  20%,  which  approximates 
the 15% intraassay variation that we have found with com- 
petitive PCR. We concluded that the RT effidency for a given 
mRNA  template was very stable and that  it was  therefore 
valid to quantitatively compare in situ RT-PCR products be- 
tween  samples. 
Glomerular Histology  and  Quantitation  of cr2IV Collagen 
mRNA.  Duplicate measurements of glomerular oe2IV col- 
lagen cDNA were performed in all patients (Table 2). These 
values were compared with the histological data. Of the nine 
patients who presented with a renal mass,  four had diffuse 
glomerulosclerosis  by  light  microscopy,  characterized  by 
moderate to severe expansion of the mesangial  matrix.  Pa- 
Table  2.  Gloraerular  Histology, Morphometry, and cr2IV 
cDNA Levels 
Relative cell  o~2IV collagen 
Patient  Sclerosis*  number*  cDNA valuesS 
Figure 1.  Competitive PCR quantitation of  cx2IV  collagen  cDNA. The 
cDNA was from a pool of 50 microdissected  glomeruli, isolated from a 
61-yr-old male patient with glomerulosclerosis  (NIH3).  (~p) Reaction 
scheme and  corresponding ethidium  bromide-stained gel  after PCR 
amplification. A  constant amount  of the  wild-type test cDNA  (wt), 
representing 1/10 of  a glomerulus, and a decreasing  amount of the mutant 
,2IV collagen cDNA were added to a series of six tubes containing all 
PCR reagents. The mutant differed  from the wt by the presence  of a 69- 
bp deletion in the middle of the molecule. Wt and mutant bands were 
analyzed  after 34 PCR cycles. (Bottom)  Ratio of mutant/wt densitometric 
values vs the amount of mutant cDNA/tube.  The amount of cDNA in 
the unknown is calculated from the equivalence  point (Y  =  1). 
WR1  -  0.85  145  +  22 
NIH4  -  0.90  174  _+  30 
WR3  -  1.13  85  +  15 
NIH1  -  0.94  190  +  32 
WR2  -  1.18  239  _+  42 
WR6  +  1.25  430  _+  120 
NIH3  +  1.35  548  +  41 
NIH2  +  1.36  775  _+  105 
WR5  +  1.08  1046  _+  74 
WR7  +  0.22  323  _+  10 
* Each kidney specimen was examined for the presence of glomerulo- 
sclerosis on light microscopy. All tissue was embedded in methacrylate 
except for WR1 and WIL7, which were paraffin embedded. 
* The relative cell number of glomerular cells was determined by mor- 
phometric analysis as outlined in detail in Materials and Methods. 
$ Data from duplicate assays, expressed as mean _+ SEM in 10 -4 atto- 
moles/glomerulus. 
1573  Peten et al. tient  WP,7,  who  underwent open  renal  biopsy  for  the 
nephrotic syndrome with severe  renal insuf~ciency, also had 
severe and diffuse glomerulosderosis with a majority of the 
glomeruli being obsolescent. The finding of glomerulosde- 
roils did not correlate with patient age or the presence of 
clinically apparent  metastatic  disease. 
Patients with severe glomerulosclerosis had a 2-6-fold in- 
crease in glomerular ol2IV collagen cDNA content (Table 
2).  The relationship  between the presence of histological 
glomerulosclerosis and the type IV collagen cDNA levels is 
illustrated in Fig. 2 for two patients.  Patient A, a 35-yr-old 
male with essentially normal glomeruli had 145  _+  22  x 
10 -4 attomoles/glomerulus in contrast to patient B, a 61- 
yr-old female with marked and diffuse glomerulosclerosis, 
who had 1046 _+  74  x  10 -4 attomoles/glomerulus of ol2IV 
collagen cDNA. In the population of 10 patients, there was 
a significant  increase  in c~2IV  collagen glomerular cDNA with 
glomerulosclerosis (624  _+  129 vs 167  _  26  x  10 -4 atto- 
moles/glomerulus, 0.01 <p <0.025 for one-way analysis). The 
possibility that the increased mP-,NA level could reflect an 
increase in glomerular cell number in the corresponding pa- 
tients was examined.  The overall glomerular relative cell 
number varied from 0.85-1.36 (Table 2), except for the spec- 
imen WP,7 in which the glomeruli were almost completely 
obsolescent. There was no significant increase in the relative 
number of cells per glomerulus in specimens with sclerosis 
when compared with normals (1.05  +  0.21 vs 1.0  +  0.07, 
p > 0.8), suggesting that there was an increased amount of 
Figure 2.  Changes in sclerotic glomeruli. (A-B) PAS-stained kidney 
sections from two unilateral nephrectomy specimens with renal carcinoma. 
(Left) Normal glomerular histology; (right) marked sclerosis. (C-D) Im- 
munofluorescence  microscopy, antibody to type IV collagen in the same 
kidneys. (E) Competitive PCR quantitation of o~2IV collagen cDNA in 
pools of 50 microdissected  glomeruli from the same kidneys  (values are 
145  -+  22 vs 1046  _+  74  x  10 -4 attomoles/glomerulus). 
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Figure 3.  Relative cell number and a2IV collagen cDNA levels. Five 
patients without glomerular sclerosis were compared with five patients 
with sclerosis. Difference between groups for the glomerular relative cell 
number was not significant (p > 0.8) whereas, for the c~2IV  collagen cDNA 
levels, the difference was statistically significant  (0.01 < p  <  0.025). 
type IV collagen cDNA on a per cell basis in the sclerotic 
glomeruli (Fig. 3). WR7 was a unique case in this analysis, 
since the glomeruli were almost completely obsolescent and 
contained only a small number of cells (Table 2). In this pa- 
tient, normalization of the c~2IV collagen cDNA level to cell 
number resulted in a value similar to WR5, a patient with 
marked sclerosis and normal-sized  glomeruli. 
Discussion 
The composition of the sclerotic matrix in humans and 
in animal models of glomerulosderosis has been extensively 
studied by immunofluorescence microscopy (1, 11). A corre- 
sponding increase in the levels  of  extracdlular matrix protein 
mRNAs has been demonstrated in isolated glomeruli from 
several animal models (12-14). Comparable studies in human 
patients have  been hampered by the fact that classical molec- 
ular biology techniques lacked the sensitivity required to assess 
the levels of glomerular extracellular matrix gene expression 
in renal biopsies. 
We studied glomeruli, microdissected from nephrectomy 
specimens, using a technique previously applied to mice (6) 
and rats (5). This method resulted in a glomerular prepara- 
tion without tubular or vascular contaminants and allowed 
the isolation of  essentially all the glomeruli available  in a renal 
biopsy core. We took advantage of the availability of renal 
tissue in nephrectomies  performed for renal carcinoma.  In 
our population of nine nephrectomies,  four of the patients 
had diffuse glomerulosclerosis which is very similar to the 
incidence of glomerulosclerosis reported in another series of 
40 patients  with renal carcinoma (15). 
ol2IV collagen mRNA was detected in all patient glomeruli, 
normal and sclerotic, using standard RT-PCR. Since the levels 
appeared to be increased in cases with glomerulosclerosis, we 
used a competitive PCR assay to provide a more accurate as- 
sessment  of the changes,  cz2IV collagen  cDNA was  fig- 
nificantly elevated  (3.7 times) in five patients with glomerulo- 
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The cDNA increase was not parallded by an increase in glo- 
merular cell number in the sclerotic glomeruli. To our knowl- 
edge, this is the first demonstration that collagen type IV 
mRNA is present in human glomeruli, and that the level 
is increased in adults with glomerulosclerosis, suggesting that 
these two events are related. It is somewhat surprising that 
the glomerular tx2IV collagen gene expression level was still 
high in a patient with extensive glomerular scarfing (WR7). 
The persistence of a high level of expression suggested that 
sclerosis  remained as an active process, even at late stages, 
a conclusion consistent with our recent observations in mice 
transgenic for bovine growth hormone (3). We found that 
glomerular cell turnover, in this mouse model, was high early 
in  the development of sderosis,  and remained elevated in 
animals with advanced glomerulosclerosis and renal failure. 
These observations, in animals and in humans, raise the pos- 
sibility that there may be a role for therapeutic intervention(s) 
at late stages of glomerular diseases. 
The assessment of mRNA levels has most often been per- 
formed on extracted RNA, a method which results in vari- 
able losses during extraction and handling of small samples. 
For this reason, we chose to utilize in situ RT of mRNA 
in microdissected and permeabilized glomeruli (5). Compar- 
ison of these two methods of preparation, performed in our 
laboratory for several different molecules in mouse (6) and 
human glomeruli (E. P.  Peten, unpublished observations), 
has always revealed a better yield of cDNA with in situ RT. 
Therefore, this method was used in the present study. 
The competitive PCR technique has been shown to be ap- 
plicable to small samples (6, 7). ct2IV collagen cDNA was 
reproducibly quantitated in as little as 1/10 of a glomerulus, 
in the range of 0.01-0.001  attomole. Although absolute values 
were obtained, the data apply only to the conditions reported 
herein, and it is to be expected that the values may change 
with further methodologic improvements. 
One of the major problems in the quantitation of mRNA 
by competitive PCR has been the potential variation in the 
efficiency of RT. Several different schemes of competitive PCR 
utilizing a cRNA mutant, rather than a cDNA mutant, have 
been recently described to address the problem of RT efficiency 
(16-18).  The underlying assumption of this approach was 
that a synthetic ~_ogenous cRNA would be reverse transcribed 
with the same efficiency as an endogenous mRNA, an un- 
proven assumption (16). Moreover, competitive PCR with 
a cRNA mutant molecule requires quantitation of the total 
extracted P,  NA, a condition not attainable in microsamples 
of extracted glomerular RNA. Total glomerular cDNA also 
cannot be quantitated. 
Another means to approach the question of RT efficiency 
is the parallel examination of a so-called housekeeping cRNA 
or cDNA molecule, the most commonly used molecules are 
GAPDH and 3-actin. However, with the increased sensitivity 
afforded by competitive PCR, we (E. P. Peten, unpublished 
observations) and others (19, 20) have found that these mRNA 
molecules were expressed at widely varying levels in various 
human and animal disease  states. 
Finally, and most importantly, the data presented herein 
in humans, and previously in mice (6), and presented by others 
for rat RNA (21), represent strong evidence that both the 
in vitro and in situ RT efficiency is very stable for a given 
molecule. Therefore, as long as the stability of the RT effidency 
is examined anew for each mRNA template, competitive PCR 
using a cDNA mutant is a reasonable method for quantita- 
tive comparisons for that  mRNA  species,  This  approach 
represents a substantial advantage for the prospective study 
of human renal biopsies. 
In conclusion, we report the detection and quautitation 
of c~2IV collagen mRNA,  after RT, in isolated glomeruli 
from a population of five patients with normal glomeruli 
and  five  patients  with  sclerotic  glomeruli.  There  was  a 
significant increase in glomerular tx2IV collagen cDNA con- 
tent in patients with glomerulosderosis. Since several different 
cDNAs, reflecting their glomerular mRNA content, could 
be  quantitated  by competitive  PCR  with  as  little  as  10 
microdissected glomeruli, this method can be applied to the 
study of percutaneous renal biopsies.  This may represent a 
more sensitive way to evaluate prognosis and treatment efficacy 
in human renal diseases. 
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